BioCardia Inc competitors

Stephen 'Steve' Isaacs is a Board Of Director at X-BIOTIX THERAPEUTICS INC; Board Member at Pan Pacific Pharmaceuticals, Inc.; and Chairman and CEO at ADURO BIOTECH, INC. and is based in Orinda, California. He has worked as Founder, President and CEO at Cerus Corporatioin; Research Staff at University of California Berkeley; and Board Member at Cerus. Stephen works or has worked as MEMBER at ABE Club. He attended University of California Berkeley.

Mr. Onsi has served as our Chief Financial Officer, Treasurer and Secretary since our inception in 2011. Mr. Onsi has been at HealthCare Ventures since 2007, including serving as a managing director since 2009 and the chief executive officer of Tensha Therapeutics, Inc. which was sold to Roche Holdings, Inc. in 2016. Prior to joining HealthCare Ventures, Mr. Onsi was at Genzyme Corporation, or Genzyme, where he served in roles as Vice President, Campath Product Operations and Portfolio Management, Oncology from 2005 to 2007 and as Vice President, Business Development from 2004 to 2005. Prior to Genzyme, he was Chief Financial Officer of Tolerx, Inc., a venture capital funded biotechnology company, from 2001 to 2004. Before joining Tolerx, Inc., he was in business development at LeukoSite, a publicly traded biopharmaceutical company that was acquired by Millennium Pharmaceuticals, Inc. He began his career as an attorney at Bingham Dana LLP. Mr. Onsi currently serves as a member of the board of directors of Vaxxas Pty Ltd., a privately-held biotechnology company. He received a Juris Doctor degree from the University of Michigan Law School and a B.S. in biological sciences from Cornell University.

Ramkumar Mandalam is a President/CEO at Cellerant Therapeutics Inc, Board Member at Cellerant Therapeutics Inc, and Board Member at Cryoport. He has experience at VERICEL CORP. Ramkumar attended University of Michigan.

Mr. Stephen Zaruby W. is a President and Chief Executive Officer at AURINIA PHARMACEUTICALS INC and is based in United States.

Michael D. West, Ph.D., is the founder and CEO of AgeX Therapeutics, Inc. He received his Ph.D. from Baylor College of Medicine in 1989 concentrating on the biology of cellular ageing. He has focused his academic and business career on the application of developmental biology to age-related degenerative disease. He was the founder and first CEO of Geron Corporation (Nasdaq: GERN), and from 1992 to 1998, he held various positions, including CEO, Director, and Vice President. From 1998 to 2007, Dr West held positions as CEO, President, and Chief Scientific Officer at Advanced Cell Technology, Inc. (ACT), which was eventually acquired by Astellas Pharma, Inc. From 2007 to 2018, he was CEO/Co-CEO of BioTime, Inc. (NYSE American: BTX).